Shaping the Future of Research at U-M

It is my pleasure to introduce myself and share our current strategies from the Michigan Medicine Office of Research. In October 2018, I was appointed by the Board of Regents to the role of interim chief scientific officer for Michigan Medicine and executive vice dean for research at the Medical School, after having served in a number of research-related positions at the Medical School and university.

For the last nine years, I have served as the senior associate dean of research for the Medical School. My personal research interests impact the field of immunology and inflammation in acute and chronic lung diseases, and the understanding of how cytokine and chemokine biology progress these diseases.

Michigan Medicine has remained dedicated to discovery research, and we continue to cultivate a vibrant and robust community of private investigators and scientists. Many people may not realize that the Medical School contributes 40 percent of all research expenditures across the entire university, followed by the College of Engineering (16 percent) and the College of Literature, Science, and the Arts (13 percent). Our $580 million in research funding, from a variety of sources, is critical to the advancement of basic science and translational research.

We have identified some crucial areas of research, such as cancer, opioid addiction, mental health, and cardiovascular diseases, and focused our investigative efforts on turning lethal diseases into chronic diseases and chronic diseases into curable diseases. We also are better equipping our researchers, learners, and staff with the tools they need to succeed. And, as we approach the 10-year anniversary of purchasing the former Pfizer research site — now our North Campus Research Complex (NCRC) — we are in the final phase of fully populating this important acquisition. This activity is part of a well-calculated plan based on renovating and maximizing our productive research space, both on our main medical campus and at NCRC, so that our scientists are not hampered by space constraints in their use of the most modern and progressive research protocols.

Another area of focus is increasing the diversity in our faculty and leadership. History has shown that collaborations between investigators with different experiences, backgrounds, and viewpoints are more likely to produce meaningful discoveries, and at a more rapid pace. When we say that we seek the "best and brightest," our reference is framed within a global context and our broader university-wide diversity initiative.

Looking to the future, I believe my charge is to continue and strengthen Michigan Medicine's commitment to attracting and retaining the best scientists in the world. I'm incredibly excited about the future of research here, and I look forward to sharing more about our strategic vision and the pivotal milestones that will help shape the next era of health care.

Steven L. Kunkel, Ph.D.
Interim Chief Scientific Officer, Michigan Medicine
Interim Executive Vice Dean for Research, Medical School
Peter A. Ward Distinguished University Professor of Pathology
Endowed Professor of Pathology Research, Department of Pathology


More Articles About: Research Basic Science funding Medical School Pathology NCRC
Featured News & Stories headshot of henry bell. he has glasses and is wearing a tuxedo with a gold and blue bowtie.
Medicine at Michigan
An early injury inspired a career in medicine
When Henry Bell Jr. was a young boy, his sister was mowing the lawn and ran over the rock, which hit him in the eye. He spent two weeks in the hospital and discovered his dream: to become an ophthalmologist.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Access to Plan B coincides with a drastic decrease in emergency contraception-related ER visits, study shows
U.S. emergency departments see 96% fewer visits, $7.6 million less in medical costs after FDA approval of over the counter emergency contraception.
Watercolor illustration of two women in conversation sitting in chairs and facing each other.
Medicine at Michigan
Q&A: Advice for an aspiring physician
A physician-scientist talks with a new medical student about what it takes to achieve career goals — and work-life balance.
black and white photo of mustafa saadi standing in front of a building
Medicine at Michigan
From investment banker to future doctor
Mustafa Saadi, M4, started in the finance world and is finding a second career in medicine.
headshot of alice zheng wearing a black blazer and purple blouse
Medicine at Michigan
Alice Zheng was once skeptical of business
The course of Alice Zheng’s life changed when she audited a class at the U-M Ross School of Business during her first year of medical school. Before taking the class, Zheng was skeptical of business. Now she’s a venture capitalist supporting women’s health.
Timothy Blackwell, M.D.
News Release
Timothy S. Blackwell, M.D., named the chair of U-M Department of Internal Medicine
Lung disease specialist comes to Michigan from Vanderbilt University School of Medicine to lead largest department